Latest Period
Q4 2025
CUSIP: 690145107
Latest Period
Q4 2025
Institutions Reporting
3
Shares (Excl. Options)
197,361
Price
$3.71
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
Latest holder context comes from 3 institutions filings for Q4 2025.
What is CUSIP 690145107?
CUSIP 690145107 identifies OM - Outset Medical, Inc. - Common Stock, par value $0.001 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Use the next link that matches the question you still need to answer about this security.
Open recent reporting periods for CUSIP 690145107:
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Durable Capital Partners LP | 9.9% | $154,630,808 | 26,609,101 | Durable Capital Partners LP | 03 Jan 2025 | |||
| PERCEPTIVE ADVISORS LLC | 9.5% | $32,688,000 | 5,625,000 | Perceptive Advisors LLC | 08 Jan 2025 | |||
| FMR LLC | 7% | $21,334,153 | 3,671,213 | FMR LLC | 31 Dec 2024 | |||
| BML Investment Partners, L.P. | 12% | $40,353,617 | 2,196,701 | BML Investment Partners, L.P. | 11 May 2026 | |||
| Alyeska Investment Group, L.P. | 9.6% | $9,896,956 | 1,703,083 | Alyeska Investment Group, L.P. | 31 Mar 2025 | |||
| PFM Health Sciences, LP | 2.9% | -72% | $1,969,253 | -$90,780,747 | 530,796 | -98% | PFM Health Sciences, LP | 31 Dec 2025 |
As of 31 Dec 2025, 3 institutional investors reported holding 197,361 shares of Outset Medical, Inc. - Common Stock, par value $0.001 per share (OM). This represents 1.1% of the company’s total 18,616,110 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 508 | $9,332 | +$3,086 | $18.37 | 1 |
| 2025 Q4 | 197,361 | $738,306 | +$79,533 | $3.71 | 3 |
| 2025 Q3 | 176,842 | $2,498,949 | +$2,006,565 | $14.12 | 3 |
| 2025 Q2 | 34,734 | $667,997 | +$195,729 | $21.73 | 2 |
| 2025 Q1 | 24,600 | $271,908 | -$26,758,605 | $5.81 | 2 |
| 2024 Q4 | 21,051,997 | $23,361,826 | -$3,640,595 | $1.11 | 73 |
| 2024 Q3 | 26,056,953 | $17,615,217 | -$39,745,792 | $0.68 | 76 |
| 2024 Q2 | 48,587,379 | $187,047,220 | -$5,223,928 | $3.85 | 118 |
| 2024 Q1 | 50,439,872 | $111,971,022 | -$20,061,860 | $2.22 | 109 |
| 2023 Q4 | 53,020,613 | $286,839,451 | -$59,832,469 | $5.41 | 137 |
| 2023 Q3 | 53,632,748 | $583,471,975 | -$2,257,141 | $10.88 | 150 |
| 2023 Q2 | 52,992,751 | $1,158,352,799 | +$26,029,052 | $21.87 | 153 |
| 2023 Q1 | 52,028,882 | $957,169,691 | +$47,145,083 | $18.40 | 159 |
| 2022 Q4 | 49,004,926 | $1,265,397,709 | +$1,900,384 | $25.82 | 147 |
| 2022 Q3 | 47,753,322 | $759,751,328 | -$60,798,422 | $15.93 | 131 |
| 2022 Q2 | 48,521,355 | $721,230,096 | -$163,983,262 | $14.86 | 143 |
| 2022 Q1 | 51,296,045 | $2,328,323,118 | +$123,798,869 | $45.40 | 147 |
| 2021 Q4 | 48,556,337 | $2,237,798,401 | -$207,141,965 | $46.09 | 153 |
| 2021 Q3 | 50,674,901 | $2,506,125,357 | +$215,826,366 | $49.44 | 138 |
| 2021 Q2 | 46,277,397 | $2,312,251,576 | +$391,010,353 | $49.98 | 126 |
| 2021 Q1 | 38,393,386 | $2,088,213,344 | +$50,139,442 | $54.39 | 109 |
| 2020 Q4 | 37,414,688 | $2,088,176,575 | +$69,477,743 | $56.84 | 110 |
| 2020 Q3 | 36,169,665 | $1,762,305,350 | +$1,762,305,350 | $50.00 | 85 |